Macrophage FABP4 is required for neutrophil recruitment and bacterial clearance in Pseudomonas aeruginosa pneumonia
暂无分享,去创建一个
C. Owen | G. Pier | L. Kobzik | H. Christou | M. Cernadas | Xiaoliang Liang | S. Çataltepe | Kushagra Gupta | Joselyn Rojas Quintero | J. R. Quintero
[1] E. Degerman,et al. White to beige conversion in PDE3B KO adipose tissue through activation of AMPK signaling and mitochondrial function , 2017, Scientific Reports.
[2] N. Møller,et al. Regulation of Lipolysis and Adipose Tissue Signaling during Acute Endotoxin-Induced Inflammation: A Human Randomized Crossover Trial , 2016, PloS one.
[3] T. van der Poll,et al. Lung epithelial MyD88 drives early pulmonary clearance of Pseudomonas aeruginosa by a flagellin dependent mechanism. , 2016, American journal of physiology. Lung cellular and molecular physiology.
[4] A. Tirosh,et al. Development of a therapeutic monoclonal antibody that targets secreted fatty acid–binding protein aP2 to treat type 2 diabetes , 2015, Science Translational Medicine.
[5] L. Gregory,et al. Pulmonary macrophages: key players in the innate defence of the airways , 2015, Thorax.
[6] T. W. Smith,et al. Fatty acid binding protein 4 expression in cerebral vascular malformations: implications for vascular remodelling , 2015, Neuropathology and applied neurobiology.
[7] Min Wang,et al. The mAb against adipocyte fatty acid-binding protein 2E4 attenuates the inflammation in the mouse model of high-fat diet-induced obesity via toll-like receptor 4 pathway , 2015, Molecular and Cellular Endocrinology.
[8] V. Salomaa,et al. Low-Expression Variant of Fatty Acid–Binding Protein 4 Favors Reduced Manifestations of Atherosclerotic Disease and Increased Plaque Stability , 2014, Circulation. Cardiovascular genetics.
[9] A. Anzueto,et al. Antibiotics for treatment and prevention of exacerbations of chronic obstructive pulmonary disease. , 2013, The Journal of infection.
[10] Marenao Tanaka,et al. Circulating Levels of Fatty Acid-Binding Protein Family and Metabolic Phenotype in the General Population , 2013, PloS one.
[11] J. Rello,et al. Risk factors for Pseudomonas aeruginosa pneumonia in the early twenty-first century , 2013, Intensive Care Medicine.
[12] H. Perlman,et al. Flow cytometric analysis of macrophages and dendritic cell subsets in the mouse lung. , 2013, American journal of respiratory cell and molecular biology.
[13] L. Boon,et al. Lipocalin 2 deactivates macrophages and worsens pneumococcal pneumonia outcomes. , 2013, The Journal of clinical investigation.
[14] E. Israel,et al. Adam8 Limits the Development of Allergic Airway Inflammation in Mice , 2013, The Journal of Immunology.
[15] G. Hotamisligil,et al. Adipocyte lipid chaperone AP2 is a secreted adipokine regulating hepatic glucose production. , 2013, Cell metabolism.
[16] J. Sousa,et al. Pseudomonas aeruginosa infection in cystic fibrosis lung disease and new perspectives of treatment: a review , 2013, European Journal of Clinical Microbiology & Infectious Diseases.
[17] S. Erzurum,et al. Fatty acid binding protein 4 regulates VEGF-induced airway angiogenesis and inflammation in a transgenic mouse model: implications for asthma. , 2013, The American journal of pathology.
[18] M. Merad,et al. Systemic Analysis of PPARγ in Mouse Macrophage Populations Reveals Marked Diversity in Expression with Critical Roles in Resolution of Inflammation and Airway Immunity , 2012, The Journal of Immunology.
[19] M. Sahin,et al. Endothelial cell-fatty acid binding protein 4 promotes angiogenesis: role of stem cell factor/c-kit pathway , 2012, Angiogenesis.
[20] S. Batra,et al. Intrapulmonary Administration of Leukotriene B4 Augments Neutrophil Accumulation and Responses in the Lung to Klebsiella Infection in CXCL1 Knockout Mice , 2012, The Journal of Immunology.
[21] L. Masana,et al. FABP4 predicts atherogenic dyslipidemia development. The PREDIMED study. , 2011, Atherosclerosis.
[22] S. Berkelhamer,et al. Fatty acid-binding proteins and peribronchial angiogenesis in bronchopulmonary dysplasia. , 2011, American journal of respiratory cell and molecular biology.
[23] Ji-Young Lee,et al. Unsaturated fatty acids repress the expression of adipocyte fatty acid binding protein via the modulation of histone deacetylation in RAW 264.7 macrophages , 2011, European journal of nutrition.
[24] L. Kobzik,et al. MARCO regulates early inflammatory responses against influenza: a useful macrophage function with adverse outcome. , 2011, American journal of respiratory cell and molecular biology.
[25] V. Yu,et al. Pneumonia due to Pseudomonas aeruginosa: part II: antimicrobial resistance, pharmacodynamic concepts, and antibiotic therapy. , 2011, Chest.
[26] J. Weingarten,et al. Pneumonia due to Pseudomonas aeruginosa: part I: epidemiology, clinical diagnosis, and source. , 2011, Chest.
[27] E. Gulbins,et al. Kinase suppressor of Ras-1 protects against pulmonary Pseudomonas aeruginosa infections , 2011, Nature Medicine.
[28] R. Evans,et al. Feeder-dependent and feeder-independent iPS cell derivation from human and mouse adipose stem cells , 2011, Nature Protocols.
[29] S. Batra,et al. CXCL1 Regulates Pulmonary Host Defense to Klebsiella Infection via CXCL2, CXCL5, NF-κB, and MAPKs , 2010, The Journal of Immunology.
[30] Baljit Singh,et al. Monocyte and macrophage heterogeneity and Toll-like receptors in the lung , 2010, Cell and Tissue Research.
[31] Jordi Rello,et al. International study of the prevalence and outcomes of infection in intensive care units. , 2009, JAMA.
[32] T. Ince,et al. Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[33] G. Pier,et al. Inescapable Need for Neutrophils as Mediators of Cellular Innate Immunity to Acute Pseudomonas aeruginosa Pneumonia , 2009, Infection and Immunity.
[34] T. Betsuyaku,et al. Epilysin (MMP-28) Restrains Early Macrophage Recruitment in Pseudomonas aeruginosa Pneumonia1 , 2009, The Journal of Immunology.
[35] M. Furuhashi,et al. Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. , 2008, The Journal of clinical investigation.
[36] M. Furuhashi,et al. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets , 2008, Nature Reviews Drug Discovery.
[37] P. Sham,et al. Serum Adipocyte Fatty Acid–Binding Protein as a New Biomarker Predicting the Development of Type 2 Diabetes , 2007, Diabetes Care.
[38] R. Parker,et al. Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2 , 2007, Nature.
[39] E. Rimm,et al. A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[40] J. Suttles,et al. The Fatty Acid-binding Protein, aP2, Coordinates Macrophage Cholesterol Trafficking and Inflammatory Activity , 2005, Journal of Biological Chemistry.
[41] Janet S. Lee,et al. Optimal timing to repopulation of resident alveolar macrophages with donor cells following total body irradiation and bone marrow transplantation in mice. , 2004, Journal of immunological methods.
[42] K. Tryggvason,et al. The Scavenger Receptor MARCO Is Required for Lung Defense against Pneumococcal Pneumonia and Inhaled Particles , 2004, The Journal of experimental medicine.
[43] A. Richmond,et al. Fine tuning the transcriptional regulation of the CXCL1 chemokine. , 2003, Progress in nucleic acid research and molecular biology.
[44] W. Garvey,et al. The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages. , 2002, Atherosclerosis.
[45] Jeffrey B. Boord,et al. Adipocyte Fatty Acid–Binding Protein, aP2, Alters Late Atherosclerotic Lesion Formation in Severe Hypercholesterolemia , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[46] Jeffrey B. Boord,et al. Lack of macrophage fatty-acid–binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis , 2001, Nature Medicine.
[47] D. Bernlohr,et al. The Mammalian Fatty Acid-binding Protein Multigene Family: Molecular and Genetic Insights into Function , 2000, Trends in Endocrinology & Metabolism.
[48] K. Kooguchi,et al. Role of Alveolar Macrophages in Initiation and Regulation of Inflammation in Pseudomonas aeruginosaPneumonia , 1998, Infection and Immunity.
[49] C. Morissette,et al. Lung phagocyte bactericidal function in strains of mice resistant and susceptible to Pseudomonas aeruginosa , 1996, Infection and immunity.
[50] Bruce M. Spiegelman,et al. Uncoupling of Obesity from Insulin Resistance Through a Targeted Mutation in aP2, the Adipocyte Fatty Acid Binding Protein , 1996, Science.
[51] J. Pittet,et al. Depletion of alveolar macrophages decreases neutrophil chemotaxis to Pseudomonas airspace infections. , 1996, The American journal of physiology.